Aarthi Scans & Labs and Origin Medical Research Lab India Private Limited – the research and development arm of Origin Medical – have announced the ongoing collaboration to advance the quality and accessibility of prenatal ultrasound care through artificial intelligence.
Over the past five years, the two organisations have worked together to develop and validate AI solutions that support maternal-fetal imaging in high-volume clinical environments, helping ensure that expecting mothers receive consistent, high-quality prenatal assessments.
The collaboration has focused on key areas of the prenatal ultrasound workflow, including automated image capture, anatomical landmark detection, real-time image quality assessment, and fetal biometry – capabilities designed to enhance workflow efficiency, reduce variability, and support clinicians in delivering more standardised prenatal care.
Commenting on the collaboration, Dr. Arunkumar Govindarajan, Radiologist and Executive Director, Aarthi Scans & Labs, said, “Prenatal ultrasound plays a critical role in monitoring fetal development and enabling timely clinical decisions during pregnancy. However, ensuring consistency and quality in fetal imaging across high-volume and diverse healthcare settings continues to be a challenge. Our collaboration with Origin Medical Research Lab is focused on addressing this gap through clinically validated AI solutions that can support radiologists and fetal medicine specialists in delivering more standardised and accurate prenatal assessments. We believe that responsible integration of AI into prenatal imaging has the potential to significantly improve access to high-quality maternal healthcare, particularly in a country like India where the demand for prenatal diagnostics continues to grow rapidly.”
The outcomes of this work, conducted in collaboration with other clinical and research partners, have been presented multiple times at leading international forums including the ISUOG World Congress and the Fetal Medicine Foundation World Congress. Across multiple studies, the AI systems demonstrated strong performance in identifying and assessing complete fetal anatomy, including critical areas such as the fetal central nervous system.
The AI systems developed as part of this collaboration include automated image capture and feedback capabilities that help clinical teams acquire complete anatomical surveys more efficiently, reducing scan times and improving patient experience. The systems also feature real-time image-quality and view-completeness checks, which provide immediate feedback to ensure required anatomical views are captured in accordance with international practice guidelines. In addition, automated fetal measurement tools help improve the consistency of fetal biometry and reduce human-to-human variability in prenatal ultrasound assessments across centres.
“Aarthi Scans & Labs has been one of our first and foundational partner for Origin Medical Research Lab from day one, and their clinical rigour, scale, and commitment to innovation have been central to the progress we have made in AI-driven prenatal imaging,” said Sripad Krishna Devalla, co-founder and CEO of Origin Medical. “Origin Medical Research Lab is the dedicated research and development arm of Origin Medical, and partnerships like this one sit at the heart of our work. Translating real-world clinical data and insights into AI solutions that are validated, scalable, and meaningful. The science developed through this collaboration continues to directly shape the technologies that Origin Medical is bringing to prenatal care settings around the world.”
As one of the early adopters of AI in healthcare and medical imaging, Aarthi Scans & Labs continues to focus on leveraging technology to improve patient care, clinical outcomes, and radiology workflows. The organisation’s adoption of AI in prenatal ultrasound is also aimed at improving accuracy and strengthening the evaluation of fetal anomalies in routine clinical practice.
This collaboration forms part of a broader vision to make affordable, accessible, and standardised prenatal care available across India. All research activities have been conducted in compliance with the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, and other applicable laws and regulations. The algorithms developed through this initiative have also undergone validation at other reputed healthcare centres.
